Prescrição de fármacos inapropriados em idosos hospitalizados: análise da mortalidade e sobrevida

Detalhes bibliográficos
Ano de defesa: 2023
Autor(a) principal: Flores, Thamara Graziela
Orientador(a): Não Informado pela instituição
Banca de defesa: Não Informado pela instituição
Tipo de documento: Tese
Tipo de acesso: Acesso aberto
dARK ID: ark:/26339/001300000hhf7
Idioma: por
Instituição de defesa: Universidade Federal de Santa Maria
Brasil
Farmacologia
UFSM
Programa de Pós-Graduação em Farmacologia
Centro de Ciências da Saúde
Programa de Pós-Graduação: Não Informado pela instituição
Departamento: Não Informado pela instituição
País: Não Informado pela instituição
Palavras-chave em Português:
Link de acesso: http://repositorio.ufsm.br/handle/1/30480
Resumo: Introduction: Elderly people (>60 years old) have a high prevalence of chronic noncommunicable diseases (DCNTs), often managed through the daily use of four or more drugs (polypharmacy). Furthermore, they may present biogerontological changes that affect the pharmacodynamics and pharmacokinetics of drugs. These situations increase the risk of adverse effects (especially geriatric syndromes), hospitalization, institutionalization and death. Therefore, several drugs are considered “potentially inappropriate medications” (MPIS) for the elderly, and these are prescribed daily in the elderly’s routine. However, the impact of the use of these drugs when used prior to hospitalization still needs to be clarified. Objective: To investigate the hospitalization profile and identify the impact of the use of inappropriate drugs prior to hospitalization on in-hospital mortality in the elderly. Methodology: Two complementary studies will be conducted. Study 1: It sought to evaluate the profile of elderly people upon admission, hospital evolution and outcome, as well as verify the association of the admission profile with the hospitalization outcome. A prospective cohort study was conducted. The variables analyzed for hospital admission were the sociodemographic profile and clinical-functional profile, as well as the evolution variables, the length of hospital stay and complications, and, as an outcome, hospital discharge or death. Study 2: approved by the Research Ethics Committee (CEP-UFSM, CAEE 48212915.50000.5346). It involved an epidemiological, prospective observational investigation in elderly people who sought emergency care and were hospitalized for various causes. Data were obtained through a structured interview that included instruments related to socioeconomic, cultural, lifestyle, health and previous daily use of MPISs and other drugs. Survival assessment was carried out up to 30 days after hospital discharge. Information on the clinical evolution of geriatric syndromes and survival was obtained via medical records. The drugs were pharmacologically categorized according to their action on the systems: nervous, cardiovascular, digestive, endocrine and osteo-muscular. The elderly were then grouped as MPIS users and non-users (control). The evolution of geriatric complications and the survival of the elderly were statistically analyzed using univariate tests and multivariate Cox regression. Results: In study 1, 493 elderly people were evaluated, with the majority of young elderly people, who lived alone, admitted to the hospital due to neoplasia. There was a positive association between death and age, Delirium, Charlson Comorbidity Index, Senior Risk Index, Frailty and calf circumference values. It was found that the elderly population that enters hospital emergency rooms presents multimorbidities, functional declines, frailty and greater exposure to adverse events during hospitalization, including death. In study 2, 318 patients aged ≥ 65 years were evaluated. The medications prescribed by these patients were recorded and the use of MPIS-ph was identified by the Brazilian consensus-based analysis of MPIS use. The impact of the use of MPIS-ph on the survival of hospitalized elderly people was determined through multivariate Cox regression analysis. Conclusions: The functional clinical profile, as well as pharmacological prescriptions, must be analyzed when creating care plans for elderly people entering in emergencies, as there are several variables that affect their outcomes.
id UFSM_8c7f8cd69dc0543435d14fd589958bc3
oai_identifier_str oai:repositorio.ufsm.br:1/30480
network_acronym_str UFSM
network_name_str Manancial - Repositório Digital da UFSM
repository_id_str
spelling Prescrição de fármacos inapropriados em idosos hospitalizados: análise da mortalidade e sobrevidaMedicamentos potencialmente inapropriadosSíndromes geriátricasHospitalizaçãoPotentially inappropriate medicationsGeriatric syndromesHospitalizationCNPQ::CIENCIAS BIOLOGICAS::FARMACOLOGIAIntroduction: Elderly people (>60 years old) have a high prevalence of chronic noncommunicable diseases (DCNTs), often managed through the daily use of four or more drugs (polypharmacy). Furthermore, they may present biogerontological changes that affect the pharmacodynamics and pharmacokinetics of drugs. These situations increase the risk of adverse effects (especially geriatric syndromes), hospitalization, institutionalization and death. Therefore, several drugs are considered “potentially inappropriate medications” (MPIS) for the elderly, and these are prescribed daily in the elderly’s routine. However, the impact of the use of these drugs when used prior to hospitalization still needs to be clarified. Objective: To investigate the hospitalization profile and identify the impact of the use of inappropriate drugs prior to hospitalization on in-hospital mortality in the elderly. Methodology: Two complementary studies will be conducted. Study 1: It sought to evaluate the profile of elderly people upon admission, hospital evolution and outcome, as well as verify the association of the admission profile with the hospitalization outcome. A prospective cohort study was conducted. The variables analyzed for hospital admission were the sociodemographic profile and clinical-functional profile, as well as the evolution variables, the length of hospital stay and complications, and, as an outcome, hospital discharge or death. Study 2: approved by the Research Ethics Committee (CEP-UFSM, CAEE 48212915.50000.5346). It involved an epidemiological, prospective observational investigation in elderly people who sought emergency care and were hospitalized for various causes. Data were obtained through a structured interview that included instruments related to socioeconomic, cultural, lifestyle, health and previous daily use of MPISs and other drugs. Survival assessment was carried out up to 30 days after hospital discharge. Information on the clinical evolution of geriatric syndromes and survival was obtained via medical records. The drugs were pharmacologically categorized according to their action on the systems: nervous, cardiovascular, digestive, endocrine and osteo-muscular. The elderly were then grouped as MPIS users and non-users (control). The evolution of geriatric complications and the survival of the elderly were statistically analyzed using univariate tests and multivariate Cox regression. Results: In study 1, 493 elderly people were evaluated, with the majority of young elderly people, who lived alone, admitted to the hospital due to neoplasia. There was a positive association between death and age, Delirium, Charlson Comorbidity Index, Senior Risk Index, Frailty and calf circumference values. It was found that the elderly population that enters hospital emergency rooms presents multimorbidities, functional declines, frailty and greater exposure to adverse events during hospitalization, including death. In study 2, 318 patients aged ≥ 65 years were evaluated. The medications prescribed by these patients were recorded and the use of MPIS-ph was identified by the Brazilian consensus-based analysis of MPIS use. The impact of the use of MPIS-ph on the survival of hospitalized elderly people was determined through multivariate Cox regression analysis. Conclusions: The functional clinical profile, as well as pharmacological prescriptions, must be analyzed when creating care plans for elderly people entering in emergencies, as there are several variables that affect their outcomes.Conselho Nacional de Pesquisa e Desenvolvimento Científico e Tecnológico - CNPqIntrodução: Idosos (>60 anos) têm alta prevalência de doenças crônicas nãotransmissíveis (DCNTs), muitas vezes manejadas através do uso diário de quatro ou mais fármacos (polifarmácia). Ainda, podem apresentar alterações biogerontológicas que afetam a farmacodinâmica e farmacocinética dos fármacos. Estas situações aumentam o risco de efeitos adversos (em especial síndromes geriátricas), hospitalização, institucionalização e morte. Desta forma, diversos fármacos são considerados “medicamentos potencialmente inapropriados” (MPIs) para idosos, e estes são prescritos diariamente na rotina de idosos. Entretanto, o impacto do uso destes fármacos quando utilizados previamente a hospitalização, ainda precisa ser esclarecido. Objetivo: Investigar o perfil de internação e identificar o impacto do uso prévio de fármacos inapropriados a internação na mortalidade intra-hospitalar de idosos. Metodologia: Dois estudos complementares serão conduzidos. Estudo 1: Buscou avaliar o perfil de idosos na admissão, evolução hospitalar e desfecho, como também verificar a associação do perfil da admissão com o desfecho da internação. Foi conduzido um estudo de coorte prospectiva. As variáveis analisadas da admissão hospitalar foram o perfil sociodemográfico e perfil clínico-funcional, já as variáveis da evolução, o tempo de internação hospitalar e complicações, e, como desfecho, a alta hospitalar ou o óbito. Estudo 2: aprovado pelo Comitê de Ética em Pesquisa (CEPUFSM, CAEE 48212915.50000.5346). Envolveu uma investigação epidemiológica, prospectiva observacional em idosos que procuraram atendimento de emergência e foram hospitalizados por diversas causas. A obtenção dos dados, foi realizada por entrevista estruturada que incluiu instrumentos relacionados a indicadores socioeconômicos, culturais, estilo de vida, saúde e uso prévio diário de MPIs e outros fármacos. A avaliação da sobrevivência foi feita até 30 dias após a alta hospitalar. Informações da evolução clínica de síndromes geriátricas e de sobrevivência foram obtidas via prontuários. Os fármacos foram farmacologicamente categorizados segundo a sua atuação nos sistemas: nervoso, cardiovascular, digestório, endócrino e ósteo-muscular. Os idosos foram então agrupados como usuários de MPISs e não usuários (controle). A evolução de complicações geriátricas e a sobrevivência dos idosos foram estatisticamente analisadas por testes univariados e pela regressão multivariada de Cox. Resultados: No estudo 1, foram avaliados 493 idosos, com maioria de idosos jovens, que moravam sozinhos, admitidos no hospital devido a neoplasia. Houve associação positiva do óbito com a idade, Delirium, índice de Comorbidades de Charlson, Índice de risco sênior, Fragilidade e valores da circunferência de panturrilha. Verificou-se que a população idosa que ingressa em emergência hospitalar apresenta multimorbidades, declínios funcionais, fragilidade e maior exposição a eventos adversos durante a internação, entre eles o óbito. No estudo 2, foram avaliados 318 pacientes com idade ≥ 65 anos. Os medicamentos que possuíam prescrição por esses pacientes foram registrados e o uso de MPIsph(Medicamentos potencialmente inapropriados prévios a internação) foi identificado pela análise brasileira baseada em consenso de uso de MPIs. O impacto do uso de MPIs-ph na sobrevida de idosos hospitalizados foi determinado por meio da análise multivariada de regressão de Cox. Conclusões: O perfil clínico funcional, assim como de prescrições farmacológicas devem ser analisados na construção dos planos de cuidados dos idosos que ingressam nas emergências, visto que diversas são as variáveis que interferem nos desfechos destes.Universidade Federal de Santa MariaBrasilFarmacologiaUFSMPrograma de Pós-Graduação em FarmacologiaCentro de Ciências da SaúdeCruz, Ivana Beatrice Mânica dahttp://lattes.cnpq.br/3426369324110716Azolin, Verônica FarinaLemos, Luiz Fernando CuozzoSchwanke , Carla Helena AugustinBarbisan, FernandaFlores, Thamara Graziela2023-11-10T18:27:51Z2023-11-10T18:27:51Z2023-09-29info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/doctoralThesisapplication/pdfhttp://repositorio.ufsm.br/handle/1/30480ark:/26339/001300000hhf7porAttribution-NonCommercial-NoDerivatives 4.0 Internationalinfo:eu-repo/semantics/openAccessreponame:Manancial - Repositório Digital da UFSMinstname:Universidade Federal de Santa Maria (UFSM)instacron:UFSM2023-11-10T18:27:52Zoai:repositorio.ufsm.br:1/30480Biblioteca Digital de Teses e Dissertaçõeshttps://repositorio.ufsm.br/PUBhttps://repositorio.ufsm.br/oai/requestatendimento.sib@ufsm.br||tedebc@gmail.com||manancial@ufsm.bropendoar:2023-11-10T18:27:52Manancial - Repositório Digital da UFSM - Universidade Federal de Santa Maria (UFSM)false
dc.title.none.fl_str_mv Prescrição de fármacos inapropriados em idosos hospitalizados: análise da mortalidade e sobrevida
title Prescrição de fármacos inapropriados em idosos hospitalizados: análise da mortalidade e sobrevida
spellingShingle Prescrição de fármacos inapropriados em idosos hospitalizados: análise da mortalidade e sobrevida
Flores, Thamara Graziela
Medicamentos potencialmente inapropriados
Síndromes geriátricas
Hospitalização
Potentially inappropriate medications
Geriatric syndromes
Hospitalization
CNPQ::CIENCIAS BIOLOGICAS::FARMACOLOGIA
title_short Prescrição de fármacos inapropriados em idosos hospitalizados: análise da mortalidade e sobrevida
title_full Prescrição de fármacos inapropriados em idosos hospitalizados: análise da mortalidade e sobrevida
title_fullStr Prescrição de fármacos inapropriados em idosos hospitalizados: análise da mortalidade e sobrevida
title_full_unstemmed Prescrição de fármacos inapropriados em idosos hospitalizados: análise da mortalidade e sobrevida
title_sort Prescrição de fármacos inapropriados em idosos hospitalizados: análise da mortalidade e sobrevida
author Flores, Thamara Graziela
author_facet Flores, Thamara Graziela
author_role author
dc.contributor.none.fl_str_mv Cruz, Ivana Beatrice Mânica da
http://lattes.cnpq.br/3426369324110716
Azolin, Verônica Farina
Lemos, Luiz Fernando Cuozzo
Schwanke , Carla Helena Augustin
Barbisan, Fernanda
dc.contributor.author.fl_str_mv Flores, Thamara Graziela
dc.subject.por.fl_str_mv Medicamentos potencialmente inapropriados
Síndromes geriátricas
Hospitalização
Potentially inappropriate medications
Geriatric syndromes
Hospitalization
CNPQ::CIENCIAS BIOLOGICAS::FARMACOLOGIA
topic Medicamentos potencialmente inapropriados
Síndromes geriátricas
Hospitalização
Potentially inappropriate medications
Geriatric syndromes
Hospitalization
CNPQ::CIENCIAS BIOLOGICAS::FARMACOLOGIA
description Introduction: Elderly people (>60 years old) have a high prevalence of chronic noncommunicable diseases (DCNTs), often managed through the daily use of four or more drugs (polypharmacy). Furthermore, they may present biogerontological changes that affect the pharmacodynamics and pharmacokinetics of drugs. These situations increase the risk of adverse effects (especially geriatric syndromes), hospitalization, institutionalization and death. Therefore, several drugs are considered “potentially inappropriate medications” (MPIS) for the elderly, and these are prescribed daily in the elderly’s routine. However, the impact of the use of these drugs when used prior to hospitalization still needs to be clarified. Objective: To investigate the hospitalization profile and identify the impact of the use of inappropriate drugs prior to hospitalization on in-hospital mortality in the elderly. Methodology: Two complementary studies will be conducted. Study 1: It sought to evaluate the profile of elderly people upon admission, hospital evolution and outcome, as well as verify the association of the admission profile with the hospitalization outcome. A prospective cohort study was conducted. The variables analyzed for hospital admission were the sociodemographic profile and clinical-functional profile, as well as the evolution variables, the length of hospital stay and complications, and, as an outcome, hospital discharge or death. Study 2: approved by the Research Ethics Committee (CEP-UFSM, CAEE 48212915.50000.5346). It involved an epidemiological, prospective observational investigation in elderly people who sought emergency care and were hospitalized for various causes. Data were obtained through a structured interview that included instruments related to socioeconomic, cultural, lifestyle, health and previous daily use of MPISs and other drugs. Survival assessment was carried out up to 30 days after hospital discharge. Information on the clinical evolution of geriatric syndromes and survival was obtained via medical records. The drugs were pharmacologically categorized according to their action on the systems: nervous, cardiovascular, digestive, endocrine and osteo-muscular. The elderly were then grouped as MPIS users and non-users (control). The evolution of geriatric complications and the survival of the elderly were statistically analyzed using univariate tests and multivariate Cox regression. Results: In study 1, 493 elderly people were evaluated, with the majority of young elderly people, who lived alone, admitted to the hospital due to neoplasia. There was a positive association between death and age, Delirium, Charlson Comorbidity Index, Senior Risk Index, Frailty and calf circumference values. It was found that the elderly population that enters hospital emergency rooms presents multimorbidities, functional declines, frailty and greater exposure to adverse events during hospitalization, including death. In study 2, 318 patients aged ≥ 65 years were evaluated. The medications prescribed by these patients were recorded and the use of MPIS-ph was identified by the Brazilian consensus-based analysis of MPIS use. The impact of the use of MPIS-ph on the survival of hospitalized elderly people was determined through multivariate Cox regression analysis. Conclusions: The functional clinical profile, as well as pharmacological prescriptions, must be analyzed when creating care plans for elderly people entering in emergencies, as there are several variables that affect their outcomes.
publishDate 2023
dc.date.none.fl_str_mv 2023-11-10T18:27:51Z
2023-11-10T18:27:51Z
2023-09-29
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/doctoralThesis
format doctoralThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://repositorio.ufsm.br/handle/1/30480
dc.identifier.dark.fl_str_mv ark:/26339/001300000hhf7
url http://repositorio.ufsm.br/handle/1/30480
identifier_str_mv ark:/26339/001300000hhf7
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Federal de Santa Maria
Brasil
Farmacologia
UFSM
Programa de Pós-Graduação em Farmacologia
Centro de Ciências da Saúde
publisher.none.fl_str_mv Universidade Federal de Santa Maria
Brasil
Farmacologia
UFSM
Programa de Pós-Graduação em Farmacologia
Centro de Ciências da Saúde
dc.source.none.fl_str_mv reponame:Manancial - Repositório Digital da UFSM
instname:Universidade Federal de Santa Maria (UFSM)
instacron:UFSM
instname_str Universidade Federal de Santa Maria (UFSM)
instacron_str UFSM
institution UFSM
reponame_str Manancial - Repositório Digital da UFSM
collection Manancial - Repositório Digital da UFSM
repository.name.fl_str_mv Manancial - Repositório Digital da UFSM - Universidade Federal de Santa Maria (UFSM)
repository.mail.fl_str_mv atendimento.sib@ufsm.br||tedebc@gmail.com||manancial@ufsm.br
_version_ 1847153403300413440